These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6754617)

  • 1. Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans.
    Diamond RD; Erickson NF
    Infect Immun; 1982 Oct; 38(1):380-2. PubMed ID: 6754617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.
    Dong ZM; Murphy JW
    Infect Immun; 1993 Dec; 61(12):5067-77. PubMed ID: 8225584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.
    Laxalt KA; Kozel TR
    Infect Immun; 1979 Nov; 26(2):435-40. PubMed ID: 397927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-chemotactic activity of capsular polysaccharide of Cryptococcus neoformans in vitro.
    Fujihara H; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1997; 41(9):657-64. PubMed ID: 9343815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.
    Swenson FJ; Kozel TR
    Infect Immun; 1978 Sep; 21(3):714-20. PubMed ID: 361575
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lopes JP; Stylianou M; Backman E; Holmberg S; Ekoff M; Nilsson G; Urban CF
    Front Cell Infect Microbiol; 2019; 9():289. PubMed ID: 31456952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
    Diamond RD; Root RK; Bennett JE
    J Infect Dis; 1972 Apr; 125(4):367-76. PubMed ID: 4553080
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotactic factors: an overview.
    Wilkinson PC
    Methods Enzymol; 1988; 162():127-32. PubMed ID: 3067049
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.
    Delfino D; Cianci L; Lupis E; Celeste A; Petrelli ML; CurrĂ³ F; Cusumano V; Teti G
    Infect Immun; 1997 Jun; 65(6):2454-6. PubMed ID: 9169790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase is a potent chemoattractant for human monocytes and neutrophils.
    Tani K; Ogushi F; Kido H; Kawano T; Kunori Y; Kamimura T; Cui P; Sone S
    J Leukoc Biol; 2000 Apr; 67(4):585-9. PubMed ID: 10770293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.
    Nosanchuk JD; Casadevall A
    Infect Immun; 1997 May; 65(5):1836-41. PubMed ID: 9125569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural cellular resistance of beige mice against Cryptococcus neoformans.
    Hidore MR; Murphy JW
    J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
    Retini C; Vecchiarelli A; Monari C; Tascini C; Bistoni F; Kozel TR
    Infect Immun; 1996 Aug; 64(8):2897-903. PubMed ID: 8757810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
    Kozel TR
    Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.
    Davies SF; Clifford DP; Hoidal JR; Repine JE
    J Infect Dis; 1982 Jun; 145(6):870-4. PubMed ID: 7045251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes.
    Wuyts A; Proost P; Put W; Lenaerts JP; Paemen L; van Damme J
    J Immunol Methods; 1994 Sep; 174(1-2):237-47. PubMed ID: 8083528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic activity of cerebrospinal fluid in experimental cryptococcal meningitis.
    Perfect JR; Durack DT
    Sabouraudia; 1985 Feb; 23(1):37-45. PubMed ID: 3992427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
    Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
    Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of neutrophil and monocyte specific chemotactic factors derived from the cornea in response to hydrogen peroxide injury.
    Elgebaly SA; Herkert N; O'Rourke J; Kreutzer DL
    Am J Pathol; 1987 Jan; 126(1):40-50. PubMed ID: 3812638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.